Daily Archives: April 8, 2022
Clinically utilized nalfurafine combined with naltrexone prevents excessive alcohol drinking and “relapse”
Alcohol addiction poses massive public health costs [~15 million adult alcoholics with economic cost > $200 billion/year in the US]. Pharmacological studies in rodents have demonstrated that kappa-opioid receptor (KOR) agonists decrease alcohol drinking and reward. However,
